Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN396389 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-LIM and SH3 Protein 1 (LASP1) (AA 1-262) antibody
- Antibody type
- Monoclonal
- Description
- This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 1-262
- Isotype
- IgG
- Antibody clone number
- 4F5
- Vial size
- 100 μg
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Submitted references Nuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer.
Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.
Integrin-dependent translocation of LASP-1 to the cytoskeleton of activated platelets correlates with LASP-1 phosphorylation at tyrosine 171 by Src-kinase.
LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinoma.
Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells.
Frietsch JJ, Grunewald TG, Jasper S, Kammerer U, Herterich S, Kapp M, Honig A, Butt E
British journal of cancer 2010 May 25;102(11):1645-53
British journal of cancer 2010 May 25;102(11):1645-53
Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.
Rose JE, Behm FM, Drgon T, Johnson C, Uhl GR
Molecular medicine (Cambridge, Mass.) 2010 Jul-Aug;16(7-8):247-53
Molecular medicine (Cambridge, Mass.) 2010 Jul-Aug;16(7-8):247-53
Integrin-dependent translocation of LASP-1 to the cytoskeleton of activated platelets correlates with LASP-1 phosphorylation at tyrosine 171 by Src-kinase.
Traenka J, Hauck CR, Lewandrowski U, Sickmann A, Gambaryan S, Thalheimer P, Butt E
Thrombosis and haemostasis 2009 Sep;102(3):520-8
Thrombosis and haemostasis 2009 Sep;102(3):520-8
LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinoma.
Wang B, Feng P, Xiao Z, Ren EC
Journal of hepatology 2009 Mar;50(3):528-37
Journal of hepatology 2009 Mar;50(3):528-37
Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells.
Salvi A, Bongarzone I, Miccichè F, Arici B, Barlati S, De Petro G
Neoplasia (New York, N.Y.) 2009 Feb;11(2):207-19
Neoplasia (New York, N.Y.) 2009 Feb;11(2):207-19
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
